TSO3 files patent application for innovations made to its sterilization systems

TSO3 Inc. ("TSO3") (TSX: TOS), an innovator in low temperature sterilization technology for medical devices in healthcare settings, through the use of ozone (a cost effective, safe and eco-friendly method) today announced that it has filed a patent application in the United States seeking protection in that market as well as preserving rights in many other countries of recent innovations made to its sterilization systems, which enable both significantly faster and gentler cycles.

This innovation will allow TSO3 to deliver sterilization cycles compatible with an increased number of simple and complex medical devices ranging from general instruments, to complex multi-channel flexible endoscopes. Cycles incorporating this technology will be added to the new STERIZONE(R) 125L Sterilizer and made available through upgrades to existing customers, once they are cleared through the appropriate regulatory authorities.

"The filing of this additional patent is part of our Intellectual Property strategy which brings substantial value to our Company", commented R.M. (Ric) Rumble, President and CEO of TSO3. "This is an exciting time for TSO3 as we are creating the Improved Standard in Healthcare Sterilization(TM). Increasing the speed and utility of our sterilizer means our customers will achieve improved throughput and we believe, eliminate the need for multiple low temperature sterilization technologies within Central Sterilization departments in hospitals".

Earlier in 2009, TSO3 outlined its plans to; increase the utility of its sterilizer though the creation of new cycles; develop relationships leading to a channel partner and increase market opportunities via expansion outside of North America. In line with these targets, in addition to today's announcement concerning the patent filing, TSO3 announced on September 2, 2009, that it had entered into a 90 days exclusive negotiation period with 3M, for the distribution of the STERIZONE(R) 125L Sterilizer including new cycles through 3M's Global Infection Prevention operation. "We are pleased with both our pace and progress towards stated goals", concluded Mr. Rumble.

Source: TSO3 INC.